Jules L. Derks

1.6k total citations
37 papers, 822 citations indexed

About

Jules L. Derks is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Jules L. Derks has authored 37 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 29 papers in Epidemiology and 20 papers in Neurology. Recurrent topics in Jules L. Derks's work include Lung Cancer Research Studies (33 papers), Neuroendocrine Tumor Research Advances (29 papers) and Neuroblastoma Research and Treatments (20 papers). Jules L. Derks is often cited by papers focused on Lung Cancer Research Studies (33 papers), Neuroendocrine Tumor Research Advances (29 papers) and Neuroblastoma Research and Treatments (20 papers). Jules L. Derks collaborates with scholars based in Netherlands, France and United Kingdom. Jules L. Derks's co-authors include Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Ronald Damhuis, Harry J.M. Groen, Egbert F. Smit, Erik Thunnissen, Robert Jan van Suylen, Esther C. van den Broek, Lynnette Fernandez‐Cuesta and Noémie Leblay and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Jules L. Derks

34 papers receiving 815 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jules L. Derks	720	633	269	215	120	37	822
Shaozhou K. Tian	334 0.5×	285 0.5×	109 0.4×	148 0.7×	45 0.4×	13	434
Mario Bavieri	285 0.4×	230 0.4×	68 0.3×	145 0.7×	44 0.4×	7	362
Dorian R.A. Swarts	390 0.5×	402 0.6×	244 0.9×	40 0.2×	48 0.4×	11	473
Anna Malczewska	704 1.0×	749 1.2×	410 1.5×	39 0.2×	77 0.6×	37	902
Nazzarena Bigiani	302 0.4×	220 0.3×	73 0.3×	134 0.6×	48 0.4×	9	422
Amanda Beras	511 0.7×	271 0.4×	77 0.3×	202 0.9×	18 0.1×	7	580
Manuela Monti	477 0.7×	448 0.7×	341 1.3×	192 0.9×	28 0.2×	47	757
Séverine Martinez	1.3k 1.8×	1.4k 2.2×	1.1k 3.9×	24 0.1×	43 0.4×	6	1.5k
Alison Langley	1.3k 1.9×	1.4k 2.3×	1.1k 4.1×	27 0.1×	44 0.4×	12	1.5k
Paula Moreno	189 0.3×	133 0.2×	66 0.2×	215 1.0×	19 0.2×	47	543

Countries citing papers authored by Jules L. Derks

Since Specialization

Citations

This map shows the geographic impact of Jules L. Derks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jules L. Derks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jules L. Derks more than expected).

Fields of papers citing papers by Jules L. Derks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jules L. Derks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jules L. Derks. The network helps show where Jules L. Derks may publish in the future.

Co-authorship network of co-authors of Jules L. Derks

This figure shows the co-authorship network connecting the top 25 collaborators of Jules L. Derks. A scholar is included among the top collaborators of Jules L. Derks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jules L. Derks. Jules L. Derks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Derks, Jules L., Dana A. M. Mustafa, Lisa M. Hillen, et al.. (2025). Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications. Laboratory Investigation. 105(11). 104234–104234.

Alcala, Nicolas, Jules L. Derks, Talya L. Dayton, et al.. (2025). Basic science and translational implications of current knowledge on neuroendocrine tumors. Journal of Clinical Investigation. 135(5). 2 indexed citations

Moonen, Laura, Jules L. Derks, Michael A. den Bakker, et al.. (2024). OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid. Modern Pathology. 38(3). 100677–100677. 3 indexed citations

Moonen, Laura, Jules L. Derks, Lisa M. Hillen, et al.. (2024). Disease relapse in relation to lymph node sampling in lung carcinoid patients. Endocrine Related Cancer. 31(9). 4 indexed citations

Moonen, Laura, Jan H. von der Thüsen, Michael A. den Bakker, et al.. (2024). Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids. Journal of Thoracic Oncology. 20(4). 451–464. 6 indexed citations

Durieux, Valérie, Wouter H. van Geffen, Hugo Arasanz, et al.. (2023). P1.28-08 Definition of Resectable Stage III Non-Small Cell Lung Cancer: A Systematic Review from EORTC Lung Cancer Group. Journal of Thoracic Oncology. 18(11). S292–S292. 2 indexed citations

Moonen, Laura, Jules L. Derks, Lisa M. Hillen, et al.. (2020). Preoperative Biopsy Diagnosis in Pulmonary Carcinoids, a Shot in the Dark. Journal of Thoracic Oncology. 16(4). 610–618. 12 indexed citations

Derks, Jules L., Harry J.M. Groen, Jos A. Stigt, et al.. (2019). Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype. Endocrine Connections. 8(12). 1600–1606. 7 indexed citations

Derks, Jules L., Erik Thunnissen, Robert Jan van Suylen, et al.. (2019). DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. Lung Cancer. 138. 102–108. 44 indexed citations

10.

Derks, Jules L., Erik Thunnissen, Robert Jan van Suylen, et al.. (2019). Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). Lung Cancer. 130. 179–186. 32 indexed citations

11.

Derks, Jules L., Robert Jan van Suylen, Michael A. den Bakker, et al.. (2018). Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). Annals of Oncology. 29. viii643–viii643. 2 indexed citations

12.

Derks, Jules L., Noémie Leblay, Erik Thunnissen, et al.. (2017). Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. Clinical Cancer Research. 24(1). 33–42. 157 indexed citations

13.

Derks, Jules L., Robert Jan van Suylen, Erik Thunnissen, et al.. (2017). Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?. European Respiratory Journal. 49(6). 1601838–1601838. 81 indexed citations

14.

Kuijpers, Chantal C. H. J., Lizza Hendriks, Jules L. Derks, et al.. (2017). Correlation of molecular status and anatomic sites of metastases (mets) at diagnosis (Dx) of non-small cell lung cancer (NSCLC). Annals of Oncology. 28. ii52–ii52. 1 indexed citations

15.

Derks, Jules L., Robert Jan van Suylen, Erik Thunnissen, et al.. (2016). A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors. Journal of Thoracic Oncology. 11(4). 593–602. 9 indexed citations

16.

Hendriks, Lizza, Jules L. Derks, Pieter E. Postmus, et al.. (2015). Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study. European Journal of Cancer. 51(17). 2534–2544. 42 indexed citations

17.

Derks, Jules L., Ernst‐Jan M. Speel, Erik Thunnissen, et al.. (2015). Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle. Journal of Thoracic Oncology. 11(3). e35–e38. 9 indexed citations

18.

Hendriks, Lizza, Jules L. Derks, Pieter E. Postmus, et al.. (2015). Single Organ Metastatic Disease, a New Prognostic Factor for Overall Survival (OS) in Stage IV Non-Small Cell Lung Cancer (NSCLC). Annals of Oncology. 26. i29–i29. 1 indexed citations

19.

Derks, Jules L., Lizza Hendriks, Wieneke A. Buikhuisen, et al.. (2015). Clinical features of large cell neuroendocrine carcinoma: a population-based overview. European Respiratory Journal. 47(2). 615–624. 90 indexed citations

20.

Mellema, Wouter W., Anne‐Marie C. Dingemans, Erik Thunnissen, et al.. (2013). KRAS Mutations in Advanced Nonsquamous Non–Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value. Journal of Thoracic Oncology. 8(9). 1190–1195. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact